Hemato-Oncology Clinic (Ahmedabad) Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
as on 26-07-2024
- Paid Up Capital ₹ 0.21 M
as on 26-07-2024
- Company Age 20 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 5.50 Cr
as on 26-07-2024
About Hemato-Oncology Clinic (Ahmedabad)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 0.21 M.
The company has closed loans amounting to ₹5.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Bhavin Shah, Chirag Desai, Sandipbhai Shah, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85110MH2004PTC416765
- Company No.
044794
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Sep 2004
- Date of AGM
05 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Hemato-Oncology Clinic (Ahmedabad) Private Limited offer?
Hemato-Oncology Clinic (Ahmedabad) Private Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Medical Treatment Services.
Who are the key members and board of directors at Hemato-Oncology Clinic (Ahmedabad)?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vashista Maniar  | Director | 29-May-2024 | Current |
| Sandipbhai Shah | Director | 23-Sep-2004 | Current |
| Chirag Desai | Director | 23-Sep-2004 | Current |
| Bhavin Shah | Director | 23-Sep-2004 | Current |
| Shailesh Talati | Director | 23-Sep-2004 | Current |
Financial Performance of Hemato-Oncology Clinic (Ahmedabad).
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Hemato-Oncology Clinic (Ahmedabad)?
Unlock access to Hemato-Oncology Clinic (Ahmedabad)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Hoc Vedanta Healthcare & Research Private LimitedActive 3 years 8 daysBhavin Shah, Chirag Desai and 2 more are mutual person
- Cellcure Cancer Centre Private LimitedActive 7 years 2 months
Bhavin Shah and Vashista Maniar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 16 Feb 2018 | ₹5.50 Cr | Satisfied |
How Many Employees Work at Hemato-Oncology Clinic (Ahmedabad)?
Unlock and access historical data on people associated with Hemato-Oncology Clinic (Ahmedabad), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hemato-Oncology Clinic (Ahmedabad), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hemato-Oncology Clinic (Ahmedabad)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
